Some great interviews. Thanks for sharing Feel very content to sit on my shares and not worry about rises and dips anymore. Will hold strong for years to come All the best holders
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling